JW PHARMACEUTICAL CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29,800 KRW | -2.30% |
|
+4.93% | -16.17% |
| Mar. 14 | JW Pharmaceutical Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Jan. 22 | CJ Logistics Secures Distribution Deal for JW Pharm's Intravenous Solutions | MT |
| Sales 2024 * | 827B 603M | Sales 2025 * | 890B 649M | Capitalization | 695B 507M |
|---|---|---|---|---|---|
| Net income 2024 * | 73B 53.22M | Net income 2025 * | 72B 52.49M | EV / Sales 2024 * | 0.97 x |
| Net Debt 2024 * | 104B 75.6M | Net Debt 2025 * | 88.55B 64.55M | EV / Sales 2025 * | 0.88 x |
| P/E ratio 2024 * |
9.75
x | P/E ratio 2025 * |
9.89
x | Employees | 1,197 |
| Yield 2024 * |
1.21% | Yield 2025 * |
1.21% | Free-Float | 52.98% |
More Fundamentals
* Assessed data
More news
| 1 day | -2.30% | ||
| 1 week | +4.93% | ||
| Current month | -8.59% | ||
| 1 month | -9.15% | ||
| 3 months | -12.09% | ||
| 6 months | +8.17% | ||
| Current year | -16.17% |
1 week
28 650.00
30 700.00
1 month
28 350.0035 150.00
Current year
28 350.0038 500.00
1 year
20 294.1251 470.59
3 years
15 943.2751 470.59
5 years
15 943.2751 470.59
10 years
10 199.8182 903.29
| Managers | Title | Age | Since |
|---|---|---|---|
Seong-Yeol Lee
CEO | Chief Executive Officer | 61 | - |
Yeong-Seob Shin
CEO | Chief Executive Officer | 61 | - |
Kyung-Ha Lee
CHM | Chairman | 60 | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kyung-Ha Lee
CHM | Chairman | 60 | - |
Seong-Yeol Lee
CEO | Chief Executive Officer | 61 | - |
Gyu-Eon Jung
BRD | Director/Board Member | 62 | - |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 34 M€ | +2.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 29,800 | -2.30% | 46 091 |
| 24-04-24 | 30,500 | +2.87% | 84,890 |
| 24-04-23 | 29,650 | 0.00% | 45,311 |
| 24-04-22 | 29,650 | +1.72% | 35,673 |
| 24-04-19 | 29,150 | -2.18% | 113,052 |
End-of-day quote Korea S.E., April 24, 2024
More quotes
JW Pharmaceutical Corp is a Korea-based company engaged in the development and manufacture of pharmaceutical products. The Company mainly produces and sells drugs including supplying protein amino acids in blood, blood and fluid substitutes, hyperlipidemia agents, electrolyte additives, angina pectoris agents, rheumatoid arthritis drugs, perfusion fluid, prostatic hypertrophy drugs, hepatic coma drugs, and iron injections, among others. The Company also researches and develops anticancer drugs.
Sector
Pharmaceuticals
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29,800
KRW
Average target price
41,667
KRW
Spread / Average Target
+39.82%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.17% | 517M | |
| +24.17% | 562B | |
| -6.33% | 358B | |
| +19.90% | 322B | |
| +7.95% | 297B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -12.26% | 149B | |
| -6.47% | 146B |
- Stock Market
- Equities
- A001060 Stock
